Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-A(y) mice

Endocrine Journal

Volumn 44, Issue 3, 1997, Pages 357-365

  Matsuzaki, Takeshi ^a   Yamazaki, Ryuta ^a   Hashimoto, Shusuke ^a   Yokokura, Teruo ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Cytokine; Diabetes; KK A(Y) mice; Lactobacillus casei; Oral administration

Indexed keywords

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; IMMUNE RESPONSE; LACTOBACILLUS CASEI; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS;

EID: 0030792512     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.44.357     Document Type: Article

References (26)

1. Nakamura M (1962) A diabetic strain of the mouse. Proc Japan Acad 38: 348-352.
2. Iwatsuka H, Taketomi S, Matsuno T (1974) Congenitally impaired hormone sensitivity of the adipose tissue of spontaneousely diabetic mice, KK. Diabetologia 10: 611-616.
3. Taketomi S, Ishikawa E, Iwatsuka H (1975) Lipogenic enzymes in two types of genetically obese animals, fatty rats and yellow KK mice. Horm Metab Res 7: 242-246.
4. Cameron DP, Poon TKY, Smith GC (1976) Effects of monosodium glutamate administration in the neonatal period on the diabetic syndrome in KK mice. Diabetologia 12: 621-626.
5. Fujiwara T, Okuno A, Yoshioka S (1995) Suppression of hepatic gluconeogenesis in long-term troglitazaone treated diabetic KK and C57BL/ KsJ-db/db mice. Metabolism 44: 486-490.
6. Nishimura M (1969) Breeding of mice strains for diabetes mellitus. Exp Animals 18: 147-157.
7. y mouse. Eur J Pharmacol 308: 205-210.
8. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A (1993) Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268: 26055-26058.
9. Horio H, Ohtsuru M (1995) Effects of administration of Grifola frondosa on glucose tolerance and glucosuria in rats with experimental diabetes. J Jpn Soc Nutr Food Sci 48: 299-305.
10. Kato I, Kobayashi S, Yokokura T (1981) Antitumor activity of Lactobacillus casei in mice. Gann 72: 517-523.
11. Matsuzaki T, Yokokura T, Azuma I (1985) Antitumor activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs. Cancer Immunol Immunother 20: 18-22.
12. Matsuzaki T, Yokokura T, Mutai M (1988) Antitumor effect of intrapleural administration of Lactobacillus casei in mice. Cancer Immunol Immunother 26: 209-214.
13. Matsuzaki T, Shimizu Y, Yokokura T (1990) Augmentation of antimetastatic effect on Lewis lung carcinoma (3LL) in C57BL/6 mice by priming with Lactobacillus casei. Med Microbiol Immunol 179: 161-168.
14. y mice" for a pharmacological assay. Endocrinol Japon 26: 185-195.
15. y. J Nutr Sci Vitaminol 38: 27-37.
16. Iwatsuka H, Shino A, Suzuoka Z (1970) General survey of diabetic features of yellow KK mice. Endocrinol Japon 17: 23-25.
17. Coleman DL (1982) Diabetes-obesity syndromes in mice. Diabetes 31 (Suppl): 1-6.
18. Olefsky JM, Nolan JJ (1995) Insulin resistance and non-insulin-dependent diabetes mellitus: Cellular and molecular mechanisms. Am J Clin Nutr 61 (Suppl): 980s-986s.
19. Harada M, Kishimoto Y, Makino S (1990) Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Research and Clinical Practice 8: 85-89.
20. Iguchi M, Inagawa H, Nishizawa T (1992) Homeostasis as regulated by activated macrophages. V. Suppression of diabetes mellitus in non-obese diabetic mice by LPSw (a lipopolysaccharide from wheat flour). Chem Pharm Bull 40: 1004-1006.
21. Konno A, Nishimura K, Hashimoto Y, Kimura S, Nishimura T (1991) Dietary restriction reduces the incidence of 3-methylcholantherene-induced tumors in mice: Close correlation with its potentiating effect on host T cell function. Cancer Immunol Immunother 33: 293-298.
22. Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor α: A key component of the obesity-diabetes link. Diabetes 43: 1271-1278.
23. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 259: 87-91.
24. Hotamisligil GS, Budavari A, Murray D (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J Clin Invest 94: 1543-1549.
25. Hotamisligil GS, Arner P, Caro JF (1995) Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95: 2409-2415.
26. Del Rey A, Besedovsky H (1989) Antidiabetic effects of interleukin 1. Pro Natl Acad Sci 86: 5943-5949.